# Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-placebo-controlled-trial-of-fluconazole-prophylaxis-for-neutropenic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Coleman Rotstein,Eric J. Bow,Michél Laverdière,Stratis Ioannou,Danielle Carr,Narguess Moghaddam,The Canadian Fluconazole Prophylaxis Study Group |
| Citations | 268 |
| DOI | 10.1086/515128 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/cid/article-pdf/28/2/331/1143614/28-2-331.pdf |
| OpenAlex ID | https://openalex.org/W2109088397 |
| PMID | 10064252 |
| Type | article |
| Year | 1999 |

## Paper authors

- [Danielle Carr](https://scholariq.org/researchers/danielle-carr/)

## Paper primary topic

- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)

## Paper topics

- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Fungal Infections and Studies](https://scholariq.org/topics/fungal-infections-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.